Skip to content
naulon

Not checkedNot checked for notices yet.

Predictors of Therapeutic Response to Beta-blockers in Patients with Heart Failure in Taiwan

Hsin Hu, Hsiang-Yiang Jui, Fu-Chang Hu and 3 more

Journal of the Formosan Medical Association · 2007

doi:10.1016/s0929-6646(08)60021-2 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Chinese are more sensitive to β-blockers than Caucasians. However, data regarding β-blocker therapy in heart failure (HF) patients in Taiwan are lacking. We aimed to evaluate the improvement of left ventricular function and the potential predictors of response to β-blocker therapy in Taiwanese HF patients. Methods: We enrolled 34 HF patients with baseline left ventricular ejection fraction (LVEF) ≤ 40%. Beta-blockers were titrated up to the maximum tolerable dose. LVEF prior to β-blocker usage and at the stable dose were obtained. We also sequenced the entire gene encoding β1-adrenoceptor to assess the relationships between LVEF improvement and gene polymorphisms. Results: Beta-blocker therapy (25 ±22 months) with a mean stable dose of 12 ± 8 mg carvedilol/day significantly improved LVEF (from 28 ±8% to 40 ± 15%, p< 0.001). Stepwise multiple linear regression analysis identified dilated cardiomyopathy (β= 18.32, p = 0.0004), baseline LVEF (β=−0.85, p = 0.0020), use of amiodarone (β = −22.58, p = 0.0034) and square of digoxin dose (β=−314.25, p = 0.0059) at stable β-blocker dose as independent predictors of LVEF improvement, where β is the estimated regression coefficient. We did not find any novel variant of β1-adrenoceptor gene other than those previously reported at codons 49 and 389, with the allele distributions similar to those found in Caucasians, and these polymorphisms did not imply therapeutic response to β-blocker. Conclusion: We demonstrated the therapeutic effects of β-blockers in Taiwanese HF patients with a dose lower than what has been reported in Western people. Moreover, patients with the etiology of dilated cardiomyopathy or lower baseline LVEF predicted a greater LVEF improvement. The β1-adrenoceptor gene polymorphisms were not responsible for the difference in sensitivity to β-blockers in this Taiwanese population.

Abstract licence: CC BY-NC-ND

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.